Novavax (NVAX) Reports In-Line Q3 EPS

Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.4 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c